| P2093 | author name string | Wesam A Ibrahim | |
| | Amal A Mohamed | |
| | Mohamed S Othman | |
| | Ahmed M Aref | |
| P2860 | cites work | Viral hepatitis and hepatocellular carcinoma | Q21245597 |
| | Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma. | Q53510185 |
| | Retarded Liver Growth in Interleukin-6-Deficient and Tumor Necrosis Factor Receptor-1-Deficient Mice1 | Q61480379 |
| | New automated dye-binding method for serum albumin determination with bromcresol purple | Q67242417 |
| | Genes for Interleukin-1, Interleukin-6, and Tumor Necrosis Factor are Expressed at Markedly Reduced Levels in the Livers of Patients with Severe Liver Disease | Q67826212 |
| | [Role of interleukin 6 in hepatocellular carcinoma] | Q71187571 |
| | Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma | Q73630418 |
| | Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group | Q73674282 |
| | Revised spectrophotometric methods for the determination of glutamic-oxalacetic transaminase, glutamic-pyruvic transaminase, and lactic acid dehydrogenase | Q78877608 |
| | Diagnosis of hepatocellular carcinoma | Q80850379 |
| | Enhanced detection of hepatocellular carcinoma | Q81419847 |
| | The significance of serum AFP cut-off values, 20 and 400 ng/mL in curatively resected patients with hepatocellular carcinoma and cirrhosis might be of difference | Q83793253 |
| | An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis | Q27860909 |
| | From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms | Q28383729 |
| | Hepatocellular carcinoma | Q29615841 |
| | Expression of the hepatocyte growth factor-like protein gene in human hepatocellular carcinoma and interleukin-6-induced increased expression in hepatoma cells | Q30654652 |
| | PROTHROMBIN: ANALYTICAL AND CLINICAL ASPECTS. COMPARISON OF THE ONE- AND TWO-STAGE METHODS | Q33354372 |
| | Enzyme immunoassays with special reference to ELISA techniques | Q33846383 |
| | Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma | Q33868508 |
| | Inhibition of STAT3 signaling blocks the anti-apoptotic activity of IL-6 in human liver cancer cells | Q34094656 |
| | Targeting the inflammation in HCV-associated hepatocellular carcinoma: a role in the prevention and treatment | Q34347862 |
| | Serum tumor markers for detection of hepatocellular carcinoma | Q34501851 |
| | Moving toward an understanding of the metastatic process in hepatocellular carcinoma | Q34538224 |
| | Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications | Q34592892 |
| | The prognostic molecular markers in hepatocellular carcinoma | Q34668320 |
| | Evaluating patients with cirrhosis for hepatocellular carcinoma: value of clinical symptomatology, imaging and alpha-fetoprotein | Q34726812 |
| | Patterns of hepatocellular carcinoma incidence in Egypt from a population-based cancer registry | Q34769250 |
| | The levels of ghrelin, leptin, TNF-alpha, and IL-6 in liver cirrhosis and hepatocellular carcinoma due to HBV and HDV infection | Q35104213 |
| | Cytokine profile in Egyptian hepatitis C virus genotype-4 in relation to liver disease progression | Q35165855 |
| | Relevance of serum levels of interleukin-6 and syndecan-1 in patients with hepatocellular carcinoma | Q35801303 |
| | Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells | Q36429815 |
| | The role of cytokines in hepatocellular carcinoma | Q36583165 |
| | The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer | Q37080407 |
| | Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention | Q37112289 |
| | Prevalence and epidemiological features of hepatocellular carcinoma in Egypt-a single center experience | Q39378220 |
| | Heme oxygenase-1: a molecular brake on hepatocellular carcinoma cell migration | Q39455035 |
| | Aflatoxins as a risk factor for hepatocellular carcinoma in Egypt, Mansoura Gastroenterology Center study. | Q39867089 |
| | High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B. | Q39997004 |
| | Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair. | Q40312537 |
| | Increased levels of interleukin-10 in serum from patients with hepatocellular carcinoma correlate with profound numerical deficiencies and immature phenotype of circulating dendritic cell subsets | Q40494233 |
| | The hepatitis C virus (HCV) induces a long-term increase in interleukin-10 production by human CD4+ T cells (H9). | Q40815673 |
| | Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression | Q41533477 |
| | Hepatitis C virus genotyping in relation to neu-oncoprotein overexpression and the development of hepatocellular carcinoma | Q42996959 |
| | Controversies in surveillance and early diagnosis of hepatocellular carcinoma. | Q43047082 |
| | Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL. | Q43604824 |
| | Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma. | Q44124129 |
| | Clinical prognostic variables in young patients (under 40 years) with hepatitis B virus-associated hepatocellular carcinoma | Q45358852 |
| | Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis | Q46524814 |
| | Possible contribution of circulating interleukin-10 (IL-10) to anti-tumor immunity and prognosis in patients with unresectable hepatocellular carcinoma | Q47334755 |
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biomarker | Q864574 |
| | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 412317 | |
| P577 | publication date | 2013-09-15 | |
| P1433 | published in | ISRN hepatology | Q27727473 |
| P1476 | title | Serum Levels of Interleukin-6 and Interleukin-10 as Biomarkers for Hepatocellular Carcinoma in Egyptian Patients | |
| P478 | volume | 2013 | |